https://www.zacks.com/stock/news/2271825/pacific-biosciences-of-california-pacb-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271825
May 09, 2024 - Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-488703946775937479
0
https://www.zacks.com/stock/news/2271809/biolife-solutions-inc-blfs-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271809
May 09, 2024 - BioLife Solutions (BLFS) delivered earnings and revenue surprises of 26.92% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-4572087186806189632
0
https://www.zacks.com/stock/news/2271812/guardant-health-gh-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271812
May 09, 2024 - Guardant Health (GH) delivered earnings and revenue surprises of 36.11% and 11.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-4052123600115833
0
https://www.zacks.com/stock/news/2271811/inseego-insg-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271811
May 09, 2024 - Inseego (INSG) delivered earnings and revenue surprises of 26.53% and 8.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-2732710160727584871
0
https://www.zacks.com/stock/news/2271820/silver-spike-investment-corp-ssic-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271820
May 09, 2024 - Silver Spike Investment (SSIC) delivered earnings and revenue surprises of -112.50% and 15.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:7554774153753117098
0
https://www.zacks.com/stock/news/2271798/integral-ad-science-ias-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271798
May 09, 2024 - Integral Ad Science (IAS) delivered earnings and revenue surprises of 50% and 2.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:7122102772834395109
0
https://www.zacks.com/stock/news/2271801/navitas-semiconductor-corporation-nvts-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271801
May 09, 2024 - Navitas Semiconductor (NVTS) delivered earnings and revenue surprises of -50% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-4027057020403324133
0
https://www.zacks.com/stock/news/2271790/anaptysbio-inc-anab-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271790
May 09, 2024 - AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:4621092144843181238
0
https://www.zacks.com/stock/news/2271793/kronos-bio-inc-kron-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271793
May 09, 2024 - Kronos Bio (KRON) delivered earnings and revenue surprises of -16.28% and 68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-6062914932307669780
0
https://www.zacks.com/stock/news/2271777/equillium-inc-eq-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271777
May 09, 2024 - Equillium (EQ) delivered earnings and revenue surprises of 52.94% and 16.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-3192007455176357823
0